#41697
Se está hablando de:
#41698
Re: Farmas USA
Si, a ver si hay suerte.
AEZS
Buenas noches
#41699
Re: Farmas USA
Con respecto al upgrade de hoy de MLV a NVAX parece ser que no hay confirmacion de tal new. :(
Esto se lo leo a un usano:
"This reiteration of the buy rating and raising the target to $14.00 does not appear to have been released yet by MLV. The advanced trading platforms showing it were fed by Benzinga Pro which is a subscription service that pride themselves in having the inside scoop on news like this before its actually news. Looking at the days activity, this looks like a damage control effort using the broader market weakness to keep it down here thanks to a premature release. Granted, that is just a guess but how else do you explain Novavax being up 6% to down 3% when the Nasdaq and the Dow were just barely positive in early trading before spiraling down to settle just off the worst levels of the day."
De hecho, si tratas de buscar la new del upgrade ... no hay modo.
NVAX
#41700
Re: Farmas USA
Farmanautas
¿Conocéis vosotros algún iluminado que de de forma más más o.menos regular y llegado el momento, rápidamente de info vía Twitter sobre las empresas relacionadas con la marihuana?
#41701
Re: Farmas USA
ACTC
Extractos del foro:
The Human Clinical Trial for Lanza's MSCs will be the shortest and the fastest trial on record for the FDA.
It will be the most dramatic, simple, but will be full of Moral Dilemmas.
It will be the best candidate ever for a Breakthough Designation, and a Phase 4 Post Marketing Approval ever that is most deserving of any Biologics candidate.
There is no need for a Placebo Arm, and I would warn the designers to be circumspect on its Inclusion and Exclusion Criteria.
This is because Life and Survival is involve... and over a very short time period.
Off all people, Lanza will agonize and think about this everyday... until it is Approved.
The Gross Numbers in terms of Mortality Rate is well established and this is the number that will be material for Comparative Purposes.
The Sepsis Etiology, Treatment, Prognosis, and Prevention... are well understood in current medical practise and standards... more specifically, the role of Inflamation relative to the survival rates is also well understood.
This will be a Combined Trial using Standard of Care Anti-Biotics and MSCs.
And the finally, The Whole World will be Focused on this Trial.
ACTC do not have the manufacturing resources, marketing resources, and operational resources to implement the commercialization of MSCs just for this one indication alone!
There are 9 other MSC Trials behind this one, including Hepatitis which infects close to 500 million people worldwide.
All of these will happen very fast, after the Sepsis data comes out!
Again... the Major Pharma Companies with Anti-Bacterial Brands will be most interested for JVs on Sepsis.
I hope people understand what a Phase 4 Post Marketing Approval is all about.
It is a trial that has no Phase 2 or 3.
It starts with Phase 1/2/3 All at the same time. One Phase.
http://investorstemcell.com/forum/groups/ceasar-s-palace-premium-d965.htm
http://investorstemcell.com/forum/groups/ceasar-s-palace-premium-d966.htm
«Después de nada, o después de todo/ supe que todo no era más que nada.»
#41702
Re: Farmas USA
«Después de nada, o después de todo/ supe que todo no era más que nada.»
#41703
Re: Farmas USA
ACTC
Se desestima la demanda por patente que le puso WARF hace cosa de unas semanas.
«Después de nada, o después de todo/ supe que todo no era más que nada.»
#41704
Re: Farmas USA
Buenos dias farmaniacos!! hoy hay os que que ser positivos. esperamos que NVAX saque su fuerza y calle muchas bocas a los malnacidos de sreet.
